MicroStrategy
MSTR
NVIDIA
NVDA
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
US Stock MarketDetailed Quotes
TYRA TYRA BIOSCIENCES, INC.
- 14.000
- -0.500-3.45%
Close Dec 20 16:00 ET
- 14.000
- 0.0000.00%
Post 17:01 ET
708.44MMarket Cap-8.70P/E (TTM)
14.960High13.880Low501.37KVolume14.300Open14.500Pre Close7.10MTurnover2.42%Turnover RatioLossP/E (Static)50.60MShares29.60052wk High1.96P/B290.35MFloat Cap11.24052wk Low--Dividend TTM20.74MShs Float31.360Historical High--Div YieldTTM7.45%Amplitude4.930Historical Low14.169Avg Price1Lot Size
About TYRA BIOSCIENCES, INC. Company
Tyra Biosciences, Inc. is a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer. Its proprietary in-house discovery platform, SN?P, enables the rapid and precise refinement of structural design through iterative molecular SN?Pshots that help predict genetic alterations most likely to cause acquired resistance to existing therapies. TYRA is developing a pipeline of selective inhibitors of the Fibroblast Growth Factor Receptor (FGFR) family members, which are altered in approximately 7% of all cancers. The company was founded by Daniel Bensen and Todd Harris on August 2, 2018 and is headquartered in Carlsbad, CA.
Company Profile
SymbolTYRA
Company NameTYRA BIOSCIENCES, INC.
Listing DateSep 15, 2021
Issue Price16.00
Founded2018
CEODr. Todd Harris, PhD
MarketNASDAQ
Employees49
Fiscal Year Ends12-31
Address2656 State Street
CityCarlsbad
ProvinceCalifornia
CountryUnited States of America
Zip Code92008
Phone1-619-728-4760
Websitehttp://www.tyra.bio
Company Executives
- Name
- Position
- Salary
- Dr. Todd Harris, PhD
- President, Chief Executive Officer and Director
- 4.63M
- Alan Fuhrman
- Chief Financial Officer and Principal Accounting Officer
- 3.53M
- Daniel Bensen
- Chief Operating Officer
- --
- Dr. Hiroomi Tada, M.D.,PhD
- Chief Medical Officer
- 2.41M
- Robert J. More
- Chairman of the Board
- 231.55K
- Rehan Verjee
- Independent Director
- 201.05K
- Dr. Jake Sin, PhD
- Independent Director
- 200.05K
- Dr. Susan Moran, M.D.
- Independent Director
- --
- Nina Kjellson
- Independent Director
- 196.05K
- Dr. Melissa McCracken, PhD
- Independent Director
- --
- Dr. S. Michael Rothenberg, M.D.
- Independent Director
- --
- Dr. Gilla Kaplan,PhD
- Independent Director
- 195.05K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.